首页> 外文期刊>Clinical drug investigation >Antipsychotic Drug Prescription in a Serbian Long-Stay Psychiatric Care Facility
【24h】

Antipsychotic Drug Prescription in a Serbian Long-Stay Psychiatric Care Facility

机译:塞尔维亚长期精神病治疗机构的抗精神病药处方

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: This study evaluated the current use of antipsychotic drugs in a long-stay psychiatric care facility.Design and Setting: The study was a cross-sectional survey of drug therapy in a long-stay psychiatric care facility, performed in the Institute for Psychiatric Care of Adults (IPCA) in Male Pcelice, Serbia, FR Yugoslavia.Patients: The drug therapy of 806 inpatients was surveyed.Interventions: The survey was performed on a randomly chosen day. The following data were collected from patient files and drug charts: age, gender, diagnosis, age of onset of illness, age of first hospitalisation, and current dosage of psycho-tropic drugs.Main Outcome Measures: The main outcome measures were the spectrum of drugs used for a particular disorder, the number of drugs used per patient, the average dose of each drug, and the average length of therapy.Results: The majority of the inpatients had schizophrenia (396) or mental retardation (330). Fifteen percent of the patients did not take any psychotropic medication. Among 682 patients taking psychotropic medication, 547 (80.2%) were receiving antipsychotics. The median daily dose of antipsychotics was 450mg of chlorpromazine (CPZ) equivalent. 133 patients (24% of those taking antipsychotics) with schizophrenia were maintained on depot antipsychotics. The dosage of antipsychotics in patients with schizophrenia was higher than that in patients with other diagnoses (median 500 vs 400mg of CPZ equivalent per day; U = 42467; p = 0.0005; significant difference). Of the patients taking antipsychotics, 237 (43.4%) were taking one, 254 (46.4%) were taking two, and 56 (10.2%) were taking three or more agents. 243 (44.4%) patients were taking an anticholinergic antiparkinsonian agent, trihexyphenidyl, in a median daily dose of 5mg. 351 (64.1%) patients were taking some other psychotropic drug. The patients receiving both antipsychotics and other psychotropic drugs were on slightly lower dosages of antipsychotics than the patients receiving antipsychotics only (median 400 vs 450mg of CPZ equivalent per day; U = 35239.8, p = 0.691; NS).Conclusions: Significant irrationalities in psychotropic drug use were observed: maintenance dosages of antipsychotics were higher than those recommended by international guidelines; two or more antipsychotics were administered to an unacceptably high proportion of patients, and adjuvant psychotropic medication was overused. There is a need for translating international guidelines into Serbian to allow Serbian practitioners to prescribe psychotropic drugs in line with modern views.
机译:目的:本研究评估了长期精神病护理机构中抗精神病药物的当前使用情况。设计与设置:这项研究是对长期精神病护理机构中药物治疗的横断面调查,由美国精神病学研究所进行患者:对806名住院患者的药物治疗进行了调查。干预措施:该调查是在随机选择的一天进行的。从患者档案和药物图表中收集了以下数据:年龄,性别,诊断,发病年龄,首次住院治疗的年龄和目前使用精神药物的剂量。主要结果指标:主要结果指标是用于特定疾病的药物,每位患者使用的药物数量,每种药物的平均剂量以及平均治疗时间。结果:大多数住院患者患有精神分裂症(396)或智力低下(330)。 15%的患者未服用任何精神药物。在682名服用精神药物的患者中,有547名(80.2%)接受了抗精神病药的治疗。抗精神病药的平均每日剂量为450mg氯丙嗪(CPZ)当量。 133位精神分裂症患者(占服用抗精神病药的24%)被维持在仓库抗精神病药中。精神分裂症患者的抗精神病药物剂量高于其他诊断者(每天CPZ当量分别为500和400mg; U = 42467; p = 0.0005;差异有统计学意义)。在服用抗精神病药的患者中,有237名(43.4%)服用了一种药物,254名(46.4%)服用了两种药物,有56名(10.2%)服用了三种或更多种药物。 243名(44.4%)患者正在服用抗胆碱能的抗帕金森病药物,三己基哌啶基,每日平均剂量为5mg。 351名(64.1%)患者正在服用其他精神药物。与仅接受抗精神病药的患者相比,同时接受抗精神病药和其他精神药物的患者的抗精神病药剂量略低(每天CPZ当量的中位数为400 vs 450mg; U = 35239.8,p = 0.691; NS)。结论:精神药物的显着非理性观察到药物使用:抗精神病药的维持剂量高于国际指南建议的剂量;对比例过高的患者使用了两种或多种抗精神病药物,并且过度使用了辅助精神药物。有必要将国际准则翻译成塞尔维亚文,以使塞尔维亚从业者可以开辟符合现代观点的精神药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号